Attached files
| file | filename |
|---|---|
| EX-31.2 - Enveric Biosciences, Inc. | ex31-2.htm |
| EX-31.1 - Enveric Biosciences, Inc. | ex31-1.htm |
| EX-10.6 - Enveric Biosciences, Inc. | ex10-6.htm |
| EX-10.5 - Enveric Biosciences, Inc. | ex10-5.htm |
| 10-Q - Enveric Biosciences, Inc. | form10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO SECTION 906
OF THE SARBANES–OXLEY ACT OF 2002
In connection with the Annual Report of Enveric Biosciences, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| May 17, 2021 | By: | /s/ David Johnson |
| David Johnson | ||
|
President and Chief Executive Officer (Principal Executive Officer) |
| May 17, 2021 | By: | /s/ Carter Ward |
| Carter Ward | ||
| Chief Financial Officer | ||
| (Principal Financial and Accounting Officer) |